Literature DB >> 2051029

Natural antibodies against bone marrow cells of a concordant xenogeneic species.

I Aksentijevich1, D H Sachs, M Sykes.   

Abstract

Hyperacute rejection does not occur when vascularized organs are transplanted between rat and mouse, and this species combination is considered to be concordant. Since hyperacute rejection is believed to reflect the presence of pre-existing antibodies (usually of the IgM class), and lymphocytotoxic antibodies against rat cells have not been detected in normal mouse sera, it has previously been concluded that mouse anti-rat natural antibody (NAb) does not exist. However, studies have not been reported in which rat bone marrow cells (BMC) were used as targets for evaluation of normal mouse sera. Because previous work from our and other laboratories has shown that bone marrow chimerism in the rat into mouse species combination can be achieved only by transplanting large numbers of rat BMC, we have evaluated normal mouse sera for the presence of NAb against rat BMC that might explain these in vivo results. Fisher 344 rat BMC and spleen cells were incubated with serum from nonimmunized mice, then stained with fluoresceinated rat anti-mouse subclass-specific secondary reagents and analyzed using flow cytometry. NAb of the IgM and IgG3 classes were found that bound strongly to rat BMC but showed weak or absent binding to spleen cells. A low level of IgG2b binding was observed to both BMC and spleen cells. Cytotoxic activity was detected against rat BMC but not against spleen cells. The environment in which the animals were maintained played a significant role in determining the level of cytotoxic NAb in normal mouse sera. Our results are consistent with the possibility that bone marrow-specific NAb play a role in resisting engraftment of BMC across this species barrier.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051029

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Mixed hematopoietic chimerism and transplantation tolerance.

Authors:  B Nikolic; M Sykes
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

2.  Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models.

Authors:  F Pan; M Tsugita; A S Rao; Y Wakizaka; H Sun; I Y Park; J J Fung; T E Starzl; L A Valdivia
Journal:  Transplant Proc       Date:  1996-04       Impact factor: 1.066

3.  Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.

Authors:  H Ohdan; Y G Yang; A Shimizu; K G Swenson; M Sykes
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 4.  IXA Honorary Member Lecture, 2017: The long and winding road to tolerance.

Authors:  Megan Sykes
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 5.  Progress in xenotransplantation: overcoming immune barriers.

Authors:  Megan Sykes; David H Sachs
Journal:  Nat Rev Nephrol       Date:  2022-10-05       Impact factor: 42.439

Review 6.  Achieving tolerance in pig-to-primate xenotransplantation: reality or fantasy.

Authors:  David H Sachs; Megan Sykes; Kazuhiko Yamada
Journal:  Transpl Immunol       Date:  2008-12-06       Impact factor: 1.708

Review 7.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 8.  Xenotransplantation tolerance: applications for recent advances in modified swine.

Authors:  Nathaly P Llore; Karina A Bruestle; Adam Griesemer
Journal:  Curr Opin Organ Transplant       Date:  2018-12       Impact factor: 2.640

9.  Mixed xenogeneic porcine chimerism tolerizes human anti-pig natural antibody-producing cells in a humanized mouse model.

Authors:  Elizabeth E Waffarn; Mohsen Khosravi-Maharlooei; Andrea Vecchione; Steven Shao; Paresh Vishwasrao; Markus A HÖlzl; Kristjana Frangaj; Megan Sykes; Hao Wei Li
Journal:  Xenotransplantation       Date:  2021-04-26       Impact factor: 3.788

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.